New Key Statistics Module, Z-Score and F-Score
NAS:INBX Key Ratios
| Market Cap $ M | 216.27 |
| Enterprise Value $ M | 15.26 |
| P/E(ttm) | 0.13 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.21 |
| Price/Sales | 135.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | 118.67 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.01 |
| EV-to-EBITDA | 0.01 |
| PEG | -- |
| Shares Outstanding M | 14.48 |
| Net Margin (%) | 112,096.11 |
| Operating Margin % | -17,775.77 |
| Pre-tax Margin (%) | 112,200.19 |
| Quick Ratio | 4.70 |
| Current Ratio | 4.70 |
| ROA % (ttm) | 1,313.65 |
| ROE % (ttm) | 1,854.62 |
| ROIC % (ttm) | -1,299.16 |
| Dividend Yield % | -- |
| Altman Z-Score | 29.63 |
INBX Number of Guru Trades
INBX Volume of Guru Trades
Gurus Latest Trades with NAS:INBX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INBX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Inhibrx Biosciences Inc Insider Transactions
No Available Data
News about NAS:INBX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers